Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

NCT03083353 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence
Smoking, Cigarette
Smoking Cessation
Smoking Behaviors
Smoking Reduction
Craving

Interventions

DRUG: Isradipine
BEHAVIORAL: Cue Exposure

Sponsor

University of Texas at Austin

Collaborators

[object Object]